Post Profile






For ripping off Medicaid, EpiPen maker Mylan pays Feds $465 million

In settlement, Myland doesn’t admit guilt for misclassifying life-saving device.
read more

share

Related Posts


Mylan to pay $465M settlement over EpiPen

Business & Finance : USAToday: Money

EpiPen maker Mylan agreed to pay $465 million in a settlement with federal regulators over its pricing practices        

The maker of EpiPen has agreed to pay the government $465 million after allegedly overcharging for the medicine

Business & Finance : Business Insider: Money Game

Mylan, the marker of the EpiPen, has agreed to pay the federal government a $465 million settlement after it allegedly overcharged government healthcare agencies for the medicine, according to a release from the firm. Mylan had unde...

Mylan to pay $465 million over EpiPen Medicaid rebate dispute

Health : Reuters: Health

(Reuters) - Mylan NV on Friday said it will pay $465 million to settle the question of whether it underpaid U.S. government healthcare programs by misclassifying its EpiPen emergency allergy treatment.

EpiPen Maker Mylan Will Pay $465 Million to Settle Medicaid Overcharging Case

Business & Finance : DealBook

Mylan said the settlement, after the government had said it improperly classified EpiPen as a generic drug, did not imply any admission of wrongdoing.

Mylan to pay $465-million settlement over Medicaid EpiPen rebates

Business & Finance : LA Times: Business

Mylan will pay $465 million to settle allegations that it overbilled Medicaid for its life-saving EpiPen allergy injection. The federal government says EpiPen is a branded drug, which means Mylan should have been paying a far higher...

Comments


Copyright © 2016 Regator, LLC